Livingston Satterthwaite
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
ERock Gains on Supply Deal and AI Surge. ERock announced a multi‑year supply agreement with HD Construction Equipment to increase engine long‑block production, adding to its backlog. The company’s service component from current orders may support its valuation. The announcement coincided with a 10% jump in the stock driven by broader AI enthusiasm.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IDEX price target raised to $285 by RBC Capital. RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.
Transaction History
| AMPX | ▲ Buy | Grant | 10,423 | $0 | 6/12/2026 | View on chart |
| EROC | ▲ Buy | Grant | 13,024 | $0 | 6/11/2026 | View on chart |
| CC | ▲ Buy | Grant | 7,182 | $0 | 5/6/2026 | View on chart |
| AMPX | ▲ Buy | Grant | 44,444 | $0 | 6/13/2025 | View on chart |
| CC | ▲ Buy | Grant | 14,096 | $0 | 4/22/2025 | View on chart |
| AMPX | ▲ Buy | Grant | 283,019 | $0 | 8/13/2024 | View on chart |
| CC | ▲ Buy | Grant | 8,547 | $0 | 8/6/2024 | View on chart |
| IEX | ▲ Buy | Grant | 745 | $0 | 5/7/2024 | View on chart |
| IEX | ▲ Buy | Grant | 770 | $0 | 5/25/2023 | View on chart |
| IEX | ▲ Buy | Option Exercise | 3,075 | $155K | 11/2/2022 | View on chart |
| IEX | ▼ Sell | Open Market | 3,075 | $685K | 11/2/2022 | View on chart |
| IEX | ▲ Buy | Grant | 825 | $0 | 5/6/2022 | View on chart |
| IEX | ▲ Buy | Option Exercise | 3,530 | $151K | 11/9/2021 | View on chart |
| IEX | ▼ Sell | Open Market | 3,530 | $831K | 11/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Amprius Technologies Announces Shelf Registration and New Coverage
Amprius Technologies (AMPX) has filed a shelf registration, indicating plans for a potential new share offering. Canaccord Genuity has begun coverage with a positive rating and set a $14 price target, while analysts maintain an average target of $23. The company’s focus on advanced battery technology has been highlighted in recent commentary, underscoring its role in the evolving energy storage market.
Amprius Technologies Announces Shelf Registration and New Coverage. Amprius Technologies (AMPX) has filed a shelf registration, indicating plans for a potential new share offering. Canaccord Genuity has begun coverage with a positive rating and set a $14 price target, while analysts maintain an average target of $23. The company’s focus on advanced battery technology has been highlighted in recent commentary, underscoring its role in the evolving energy storage market.